{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Hayashi M"],"funding":["Austrian Science Fund FWF","Alberta Health Services Cardiovascular Health and Stroke Strategic Clinical Network"],"pagination":["139"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9680290"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["10(6)"],"pubmed_abstract":["<h4>Background</h4>Despite evidence of clinical utility and the availability of prescription guidelines, pharmacogenomics (PGx) is not broadly used in institutional settings in Canada. To inform future implementation, this study aimed to identify healthcare provider knowledge, experience, and perceptions of PGx in Alberta, Canada.<h4>Methods</h4>An online 44-item survey was distributed to pharmacists, nurse practitioners, and physicians employed or contracted with Alberta Health Services from January to May 2022. Questions included: demographics, professional history, PGx education and exposure, knowledge, and ability to use PGx, and attitudes towards, feasibility, clinical utility, education, and implementation.<h4>Results</h4>Ninety-one pharmacists, 37 nurse practitioners, and 6 physicia"],"journal":["Pharmacy (Basel, Switzerland)"],"pubmed_title":["Experience, Knowledge, and Perceptions of Pharmacogenomics among Pharmacists and Nurse Practitioners in Alberta Hospitals."],"pmcid":["PMC9680290"],"funding_grant_id":["N/A","P 26471"],"pubmed_authors":["Bousman CA","Hayashi M"],"additional_accession":[]},"is_claimable":false,"name":"Experience, Knowledge, and Perceptions of Pharmacogenomics among Pharmacists and Nurse Practitioners in Alberta Hospitals.","description":"<h4>Background</h4>Despite evidence of clinical utility and the availability of prescription guidelines, pharmacogenomics (PGx) is not broadly used in institutional settings in Canada. To inform future implementation, this study aimed to identify healthcare provider knowledge, experience, and perceptions of PGx in Alberta, Canada.<h4>Methods</h4>An online 44-item survey was distributed to pharmacists, nurse practitioners, and physicians employed or contracted with Alberta Health Services from January to May 2022. Questions included: demographics, professional history, PGx education and exposure, knowledge, and ability to use PGx, and attitudes towards, feasibility, clinical utility, education, and implementation.<h4>Results</h4>Ninety-one pharmacists, 37 nurse practitioners, and 6 physicia","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Oct","modification":"2025-04-04T13:28:12.818Z","creation":"2025-04-04T13:28:12.818Z"},"accession":"S-EPMC9680290","cross_references":{"pubmed":["36412815"],"doi":["10.3390/pharmacy10060139"]}}